Investigating early proteins in Valley Fever infection and their role in immune response and vaccines
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis
This study is looking at how certain proteins behave early in Valley Fever infections to help find ways to create better vaccines and treatments, which could ultimately help patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northern Arizona University NIH-funded |
| Lab location | 1 site (Flagstaff, United States) |
| Project ID | NIH-10899654 on NIH RePORTER |
What this research studies
This research focuses on understanding the proteins that are expressed early during the infection cycle of coccidioidomycosis, also known as Valley Fever. By using animal models, including invertebrates and mice, the researchers aim to identify virulence factors that contribute to the disease's progression. The study will explore how these proteins can inform the development of vaccines and improve immune responses against the infection. Patients may benefit from insights gained in this research, which could lead to better prevention and treatment strategies for Valley Fever.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of coccidioidomycosis, particularly those living in endemic areas.
Not a fit: Patients who have already been diagnosed with chronic or severe coccidioidomycosis may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines and improved treatments for Valley Fever.
How similar studies have performed: Other research has shown promise in identifying virulence factors in fungal infections, suggesting that this approach could yield valuable insights.
Where this research is happening
Flagstaff, United States
- Northern Arizona University — Flagstaff, United States (Active)
Researchers
- Principal investigator: Barker, Bridget Marie — Northern Arizona University
- Study coordinator: Barker, Bridget Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.